Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Sodium glycerophosphate anhydrous
CAS 1334-74-3
Concern score
Not assessed — no hazard data yet.
Why it's flagged
EPA DSSTox provides the canonical identifier, structure, and synonym profile for this chemical.
Regulation
No restrictions found. Sodium glycerophosphate anhydrous appears in these published regulatory listings.
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- ingredient_type:ingredient substance
- marketed_drug_ingredient
- nsde_reference_present
- substance_class:mixture
- substance_type:mixture
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 2 active drug products and 2 total products.
- FDA NDC lists this ingredient in 2 active drug products and 2 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as mixture.
- openFDA substance registry classifies this ingredient as mixture.Source →
Evidence
No graded sources yet for Sodium glycerophosphate anhydrous. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Sodium glycerophosphate anhydrous in our catalog (fda_ndc).
Products
2
